Cervical Myelopathy in Hip Fracture Patients
Indiana University
75 participants
May 1, 2025
INTERVENTIONAL
Conditions
Summary
Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated.
Eligibility
Inclusion Criteria1
- Patient admitted to Eskenazi, Methodist, or IU North hospital for a hip fracture (femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fracture) that was caused by a ground level fall.
Exclusion Criteria2
- Neurologic or cognitive disorder explaining the fall (dementia, Parkinson's disease, delirium, etc.)
- Syncopal fall or fall caused by stroke or a heart condition
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants whose history and physical exam indicate signs or symptoms of cervical myelopathy will be scheduled for a cervical MRI.
A history and physical exam to evaluate for specific signs and symptoms of cervical myelopathy will be performed.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06893406